Doyle Wealth Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-18
Closed -$1K – 285
2018
Q4
$1K Buy
+18
New +$1.55K ﹤0.01% 819

Other funds holding CLB

Doyle Wealth Management's CLB Position: Q1 2019 in Review

Doyle Wealth Management sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 18 shares — an estimated $1K sold.

Doyle Wealth Management first reported a position in CLB in Q4 2018 and held it in 1 quarter. The position peaked at $1K in Q4 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

  • Doyle Wealth Management reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 18 Core Laboratories shares in Q1 2019, an estimated $1K.
  • Doyle Wealth Management first reported a position in Core Laboratories in Q4 2018 and held it in 1 quarter.
  • Doyle Wealth Management's Core Laboratories position peaked at $1K in Q4 2018.
  • 313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on Doyle Wealth Management's 13F filing for Q1 2019, filed 13 May 2019.